To evaluate the therapeutic effect of TNF-α blockade, we treated 5-mo-old DNase II−/−STINGS365A/S365A mice that had already developed arthritis with anti–TNF-α (Fig. 6, D and E). This evidence concerns the gene TNF and arthritic joint disease.